MYC and neoplasm: We reanalysed RNA-seq datasets derived from this mouse model and found a lower level of MYC and E2F targets in TICs than in the rest of the tumour cells, a trend that was also unique to MYC among the downstream transcription factors of the RAS–MAPK pathway examined (Extended Data Fig. 5e).